HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Nakaraang pagsara
$0.11
Sakop ng araw
$0.11 - $0.12
Sakop ng taon
$0.045 - $0.26
Market cap
34.92M AUD
Average na Volume
403.39K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 158.95K | — |
Gastos sa pagpapatakbo | 1.04M | 353.66% |
Net na kita | -849.71K | -362.36% |
Net profit margin | -534.56 | — |
Kita sa bawat share | — | — |
EBITDA | -597.26K | -188.01% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.36M | 41.48% |
Kabuuang asset | 16.66M | 232.64% |
Kabuuang sagutin | 207.86K | 699.36% |
Kabuuang equity | 16.45M | — |
Natitirang share | 332.58M | — |
Presyo para makapag-book | 2.10 | — |
Return on assets | -13.63% | — |
Return on capital | -13.81% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -849.71K | -362.36% |
Cash mula sa mga operasyon | -454.20K | -97.14% |
Cash mula sa pag-invest | -2.62M | — |
Cash mula sa financing | — | — |
Net change in cash | -3.08M | -1,236.52% |
Malayang cash flow | -158.67K | -30.24% |
Tungkol
Itinatag
2002
Website